Orsted reported another encouraging Q3 22 with EBITDA up by 313% to DKK12.317bn vs Q3 21, leading the Danish offshore giant to upgrade its FY2022 guidance by DKK1bn. Here again, the outlook was driven by a good performance in the Bioenergy & other segment, amid volatile energy prices, offsetting the decrease in offshore and onshore wind power generation. The group also conserves its dynamic in renewable investments which also supported in its EBITDA guidance increase.

04 Nov 2022
Q3 22: another quarter supported by Bioenergy & other segment

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q3 22: another quarter supported by Bioenergy & other segment
- Published:
04 Nov 2022 -
Author:
Olivier de Wismes -
Pages:
3 -
Orsted reported another encouraging Q3 22 with EBITDA up by 313% to DKK12.317bn vs Q3 21, leading the Danish offshore giant to upgrade its FY2022 guidance by DKK1bn. Here again, the outlook was driven by a good performance in the Bioenergy & other segment, amid volatile energy prices, offsetting the decrease in offshore and onshore wind power generation. The group also conserves its dynamic in renewable investments which also supported in its EBITDA guidance increase.